185 related articles for article (PubMed ID: 31441983)
21. Impact of Toceranib/Piroxicam/Cyclophosphamide Maintenance Therapy on Outcome of Dogs with Appendicular Osteosarcoma following Amputation and Carboplatin Chemotherapy: A Multi-Institutional Study.
London CA; Gardner HL; Mathie T; Stingle N; Portela R; Pennell ML; Clifford CA; Rosenberg MP; Vail DM; Williams LE; Cronin KL; Wilson-Robles H; Borgatti A; Henry CJ; Bailey DB; Locke J; Northrup NC; Crawford-Jakubiak M; Gill VL; Klein MK; Ruslander DM; Thamm DH; Phillips B; Post G
PLoS One; 2015; 10(4):e0124889. PubMed ID: 25923466
[TBL] [Abstract][Full Text] [Related]
22. Use of single-agent carboplatin as adjuvant or neoadjuvant therapy in conjunction with amputation for appendicular osteosarcoma in dogs.
Phillips B; Powers BE; Dernell WS; Straw RC; Khanna C; Hogge GS; Vail DM
J Am Anim Hosp Assoc; 2009; 45(1):33-8. PubMed ID: 19122062
[TBL] [Abstract][Full Text] [Related]
23. Prognostic significance of circulating microRNA-214 and -126 in dogs with appendicular osteosarcoma receiving amputation and chemotherapy.
Heishima K; Meuten T; Yoshida K; Mori T; Thamm DH
BMC Vet Res; 2019 Jan; 15(1):39. PubMed ID: 30683101
[TBL] [Abstract][Full Text] [Related]
24. Adjuvant carboplatin and gemcitabine combination chemotherapy postamputation in canine appendicular osteosarcoma.
McMahon M; Mathie T; Stingle N; Romansik E; Vail D; London C
J Vet Intern Med; 2011; 25(3):511-7. PubMed ID: 21488959
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of P16 expression in canine appendicular osteosarcoma.
Murphy BG; Mok MY; York D; Rebhun R; Woolard KD; Hillman C; Dickinson P; Skorupski K
BMC Vet Res; 2017 Jun; 13(1):189. PubMed ID: 28633676
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of toxicities from combined metronomic and maximal-tolerated dose chemotherapy in dogs with osteosarcoma.
Bracha S; Walshaw R; Danton T; Holland S; Ruaux C; Obradovich J
J Small Anim Pract; 2014 Jul; 55(7):369-74. PubMed ID: 24803081
[TBL] [Abstract][Full Text] [Related]
27. What do we know about canine osteosarcoma treatment? Review.
Szewczyk M; Lechowski R; Zabielska K
Vet Res Commun; 2015 Mar; 39(1):61-7. PubMed ID: 25422073
[TBL] [Abstract][Full Text] [Related]
28. Canine osteosarcoma: amputation and chemotherapy.
Berg J
Vet Clin North Am Small Anim Pract; 1996 Jan; 26(1):111-21. PubMed ID: 8825570
[TBL] [Abstract][Full Text] [Related]
29. Effects of the potassium-sparing diuretic amiloride on chemotherapy response in canine osteosarcoma cells.
Poon AC; Inkol JM; Luu AK; Mutsaers AJ
J Vet Intern Med; 2019 Mar; 33(2):800-811. PubMed ID: 30556178
[TBL] [Abstract][Full Text] [Related]
30. Alternating carboplatin and doxorubicin as adjunctive chemotherapy to amputation or limb-sparing surgery in the treatment of appendicular osteosarcoma in dogs.
Kent MS; Strom A; London CA; Seguin B
J Vet Intern Med; 2004; 18(4):540-4. PubMed ID: 15320595
[TBL] [Abstract][Full Text] [Related]
31. Proximal radial and distal humeral osteosarcoma in 12 dogs.
Liptak JM; Dernell WS; Straw RC; Rizzo SA; Lafferty MH; Withrow SJ
J Am Anim Hosp Assoc; 2004; 40(6):461-7. PubMed ID: 15533966
[TBL] [Abstract][Full Text] [Related]
32. Canine osteosarcoma. Treatment by amputation versus amputation and adjuvant chemotherapy using doxorubicin and cisplatin.
Mauldin GN; Matus RE; Withrow SJ; Patnaik AK
J Vet Intern Med; 1988; 2(4):177-80. PubMed ID: 3230557
[TBL] [Abstract][Full Text] [Related]
33. Palliative radiotherapy with electrons of appendicular osteosarcoma in 54 dogs.
Mueller F; Poirier V; Melzer K; Nitzl D; Roos M; Kaser-Hotz B
In Vivo; 2005; 19(4):713-6. PubMed ID: 15999538
[TBL] [Abstract][Full Text] [Related]
34. Use of an artificial lymphatic system during carboplatin infusion to improve canine osteosarcoma blood flow and clinical response.
DiResta GR; Aiken SW; Brown HK; Bergman PJ; Hohenhaus A; Ehrhart EJ; Baer K; Healey JH
Ann Surg Oncol; 2007 Aug; 14(8):2411-21. PubMed ID: 17503157
[TBL] [Abstract][Full Text] [Related]
35. Cisplatin and doxorubicin combination chemotherapy for the treatment of canine osteosarcoma: a pilot study.
Chun R; Kurzman ID; Couto CG; Klausner J; Henry C; MacEwen EG
J Vet Intern Med; 2000; 14(5):495-8. PubMed ID: 11012111
[TBL] [Abstract][Full Text] [Related]
36. Pharmacokinetic study and evaluation of the safety of taurolidine for dogs with osteosarcoma.
Marley K; Helfand SC; Simpson J; Mata JE; Tracewell WG; Brownlee L; Bracha S; Séguin B
J Exp Clin Cancer Res; 2013 Oct; 32(1):74. PubMed ID: 24422857
[TBL] [Abstract][Full Text] [Related]
37. Enrofloxacin enhances the effects of chemotherapy in canine osteosarcoma cells with mutant and wild-type p53.
York D; Withers SS; Watson KD; Seo KW; Rebhun RB
Vet Comp Oncol; 2017 Sep; 15(3):1087-1100. PubMed ID: 27333821
[TBL] [Abstract][Full Text] [Related]
38. Toxicity and efficacy of cisplatin and doxorubicin combination chemotherapy for the treatment of canine osteosarcoma.
Chun R; Garrett LD; Henry C; Wall M; Smith A; Azene NM
J Am Anim Hosp Assoc; 2005; 41(6):382-7. PubMed ID: 16267062
[TBL] [Abstract][Full Text] [Related]
39. Video-assisted microwave ablation for the treatment of a metastatic lung lesion in a dog with appendicular osteosarcoma and hypertrophic osteopathy.
Mazzaccari K; Boston SE; Toskich BB; Bowles K; Case JB
Vet Surg; 2017 Nov; 46(8):1161-1165. PubMed ID: 28940654
[TBL] [Abstract][Full Text] [Related]
40. Treatment of dogs with osteosarcoma by administration of cisplatin after amputation or limb-sparing surgery: 22 cases (1987-1990).
Berg J; Weinstein MJ; Schelling SH; Rand WM
J Am Vet Med Assoc; 1992 Jun; 200(12):2005-8. PubMed ID: 1639715
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]